February 1, 2023 The Health Innovation Roundup, sponsored by Health Cities, is written and published weekly by Taproot Edmonton to bring you the latest news and events in research, technology, companies and people changing health for the better in Edmonton.Sign up to get the full edition delivered directly to your inbox. Use the code HEALTHCITY & you’ll get 10% off the first year.Here are some highlights from this week’s Health Innovation Roundup: HeadlinesPulseMedica will receive funding from INOVAIT’s Focus Fund as one of 14 commercialization-focused projects in image-guided therapy. The Edmonton-based company’s project will have access to almost $2 million over the next three years to further machine-learning-enabled imaging, classification, and treatment of symptomatic vitreous opacities and other conditions affecting the retina.Seven Edmonton-based companies have made the top 20 for the Life Sciences Investment Summit from Startup TNT. Bio-Stream Diagnostics, FentaGone, IMBiotechnologies, KARMED, Mosaic Sensors, Nanostics, and Northernmost will compete against 13 other companies on Feb. 9 for a chance to pitch to investors at the finale on March 23.Tiny HeartsCan Foundation is participating in BoostUp: A Cardiac Pitch Competition on Feb. 9. It will be competing with five other projects for $10,000 from the Western Canadian Children’s Heart Network, which the organization says would allow it to “provide up to 20 hands-on fetal cardiac training sessions for sonographers across Western Canada.”Sindhu Nair of Q Boost Inc. spoke to the Health Innovation Hub newsletter about what health innovation means to her.The Alberta Diabetes Institute at the University of Alberta will be part of a dose-finding study with Adhera Therapeutics in the US. The study’s results will allow for the optimization of dose range in treatment for Type 1 diabetes.48Hour Discovery is presenting to global investors at the 2023 OBIO Investment Summit in Toronto.Researchers from Nanostics contributed to a paper called Model Atmospheric Aerosols Convert to Vesicles upon Entry into Aqueous Solution that earned the cover of the ACS Earth and Space Chemistry publication.Researchers in the Department of Biological Sciences at the University of Alberta are exploring how fungi become resistant to antifungal drugs. “Antimicrobial drugs are fundamental for us to live healthy lives,” Daniel Charlebois, co-author of a study related to the research, told Folio. “Trying to understand how these non-genetic mechanisms influence evolution is really interesting for drug resistance, which is an evolutionary process.”The 24th annual Corus Radiothon raised over $1.8 million in support of the Stollery Children’s Hospital. The radiothon has raised over $29 million since 2000.EventsFeb. 9, 7am: Health Cities Breakfast: A New Lens on Health and Prevention at the Foundry RoomFeb. 9, 4pm: Life Sciences Summit: Top 20 Pitch Night, presented by Startup TNT and APIFeb. 16, 4pm: Health Innovators’ Meetup: Get To Know Your Investors at Enterprise SquareFeb. 21, 12pm: AI Meetup: Tackling healthcare projects using federated learning from AmiiFeb. 23, 12pm: Digitizing & Automating Mental Health Treatment, presented by Lenica Research GroupMarch 23: Life Sciences Investment Summit Finale in CalgaryBecome a “Roundup Cultivator” and sponsor Taproot Edmonton to help them chronicle health innovation in Edmonton. Learn more